Literature DB >> 7584139

Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M(r) component of the C1q receptor.

A J Tenner1, S L Robinson, R A Ezekowitz.   

Abstract

Mannose-binding protein (MBP), C1q, the recognition component of the classical complement pathway, and pulmonary surfactant protein A (SP-A) are members of a family of molecules containing a collagen-like sequence contiguous with a noncollagen-like sequence, and usually having the properties of a lectin. C1q and SP-A have been shown to enhance monocyte FcR- and CR1-mediated phagocytosis, suggesting that the common structural features of the collagen-like domains may provide a basis for this immunologically important function. Results presented here demonstrate that MBP also enhanced FcR-mediated phagocytosis by both monocytes and macrophages, and stimulated CR1-mediated phagocytosis in human culture-derived macrophages and in phorbol ester-activated monocytes. Furthermore, a monoclonal antibody that recognizes a 126,000 M(r) cell surface protein and inhibits C1q-enhanced phagocytosis, inhibited the MBP-mediated enhancement of phagocytosis. Thus, the receptors that mediate the enhancement of phagocytosis by MBP and C1q share at least one critical functional component, the 126,000 M(r) ClqRP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7584139     DOI: 10.1016/1074-7613(95)90177-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  29 in total

Review 1.  C1q receptors.

Authors:  P Eggleton; A J Tenner; K B Reid
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

2.  Modulated interaction of the ERM protein, moesin, with CD93.

Authors:  Mingyu Zhang; Suzanne S Bohlson; Marisela Dy; Andrea J Tenner
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

3.  The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy.

Authors:  K Csencsits; B E Burrell; G Lu; E J Eichwald; G L Stahl; D K Bishop
Journal:  Am J Transplant       Date:  2008-06-28       Impact factor: 8.086

4.  Complement component C1q regulates macrophage expression of Mer tyrosine kinase to promote clearance of apoptotic cells.

Authors:  Manuel D Galvan; Deborah B Foreman; Erliang Zeng; John C Tan; Suzanne S Bohlson
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

5.  Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement.

Authors:  Rema Rajagopalan; Takazvida Nyaundi; Veena P Salvi; Nenoo Rawal
Journal:  Mol Immunol       Date:  2010-06-25       Impact factor: 4.407

6.  Changes in the mannan binding lectin (MBL) concentration in human milk during lactation.

Authors:  Virginie Trégoat; Paul Montagne; Marie-Christine Béné; Gilbert Faure
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

7.  Novel collectin/C1q receptor mediates mast cell activation and innate immunity.

Authors:  Brian T Edelson; Thomas P Stricker; Zhengzhi Li; S Kent Dickeson; Virginia L Shepherd; Samuel A Santoro; Mary M Zutter
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

8.  Protection from inflammatory disease in insulin resistance: the role of mannan-binding lectin.

Authors:  J M Fernández-Real; M Straczkowski; J Vendrell; F Soriguer; S Pérez Del Pulgar; L Gallart; A López-Bermejo; I Kowalska; M Manco; F Cardona; M M García-Gil; G Mingrone; C Richart; W Ricart; A Zorzano
Journal:  Diabetologia       Date:  2006-08-29       Impact factor: 10.122

9.  Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin.

Authors:  Gregory T Spear; M Reza Zariffard; Ji Xin; Mohammed Saifuddin
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

10.  Superoxide production from human polymorphonuclear leukocytes by human mannan-binding protein (MBP).

Authors:  Kazuhide Uemura; Harumi Yamamoto; Tomoaki Nakagawa; Kishiko Nakamura; Nobuko Kawasaki; Shogo Oka; Bruce Yong Ma; Toshisuke Kawasaki
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.